ABBOTT LABORATORIES for ABBOTT LABORATORIES
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2012 | $540,000 | Replaced |
| 2nd Quarter - Report (this page) | Oct 22, 2012 | $1,790,000 | Yes |
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade issues regarding the Trans-Pacific Partnership Agreement S.3285, A bill to authorize the extension of of nondiscriminatory treatment (normal trade relations treatment) to products of the Russian Federation. International Intellectual property protection
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | — |
| JASON GROVE | — |
| ELAINE R LEAVENWORTH | — |
| KRISTEN DW MORRIS | — |
Agriculture AGR
Initiatives regarding infant nutrition
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE FERGUSON | — |
| ELAINE R LEAVENWORTH | — |
| KRISTEN DW MORRIS | — |
Taxation/Internal Revenue Code TAX
Proposals to reform domestic and international tax structures R & D Tax Credit, Controlled Foreign Corporation look-through
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSEMARY T HAAS | — |
| ELAINE R LEAVENWORTH | — |
| KRISTEN DW MORRIS | — |
| ADELE R WITENSTEIN | — |
Medicare/Medicaid MMM
Proposals to modify DMEPOS reimbursement in Medicare Medicare payment proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSEMARY T HAAS | — |
| ELAINE R LEAVENWORTH | — |
| KRISTEN DW MORRIS | — |
| CYNTHIA B SENSIBAUGH | — |
| ADELE R WITENSTEIN | — |
Budget/Appropriations BUD
Implementation of Public Law 112-25, The Budget Control Act of 2011 H.R.5973, Agriculture, Rural Development, Food and Drug Adminstration, and Related Agencies Appropriations Act, 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELAINE R LEAVENWORTH | — |
| KRISTEN DW MORRIS | — |
| ADELE R WITENSTEIN | — |
Financial Institutions/Investments/Securities FIN
Implementation of Section 1502, Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSEMARY T HAAS | — |
| ELAINE R LEAVENWORTH | — |
| KRISTEN DW MORRIS | — |
Health Issues HCR
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE FERGUSON | — |
| JOHN P FORD | — |
| JASON GROVE | — |
| ROSEMARY T HAAS | — |
| ELAINE R LEAVENWORTH | — |
| KRISTEN DW MORRIS | — |
| CYNTHIA B SENSIBAUGH | — |
| ADELE R WITENSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.